Genixus
Kannapolis
About Genixus
Genixus develops healthcare products. They design and produce ready-to-administer injectables that set the standard for clinician experience using the solutions they manufacture and provide. They deliver ready-to-use, error-proof medications to acute and critical care. Genixus simplifies acute and critical care medications as much as possible, allowing providers to focus on improving and extending lives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.0M
- Last round: Series Unknown (Jan 2022)
- Website: genixus.com
- Phone: [email protected]
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/genixus-47438 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.